Kennedy Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,131
| Closed | -$64.2K | – | 739 |
|
|
2024
Q1 | $64.2K | Buy |
+17,131
| New | +$64.2K | ﹤0.01% | 721 |
|
|
2023
Q3 | – | Sell |
-27,012
| Closed | -$359K | – | 701 |
|
|
2023
Q2 | $359K | Buy |
+27,012
| New | +$359K | 0.01% | 625 |
|
|
2023
Q1 | – | Sell |
-241,727
| Closed | -$1.98M | – | 640 |
|
|
2022
Q4 | $1.98M | Sell |
241,727
-107,200
| -31% | -$877K | 0.06% | 415 |
|
|
2022
Q3 | $2.03M | Buy |
+348,927
| New | +$2.03M | 0.06% | 414 |
|
|
2022
Q1 | – | Sell |
-220,106
| Closed | -$4.5M | – | 626 |
|
|
2021
Q4 | $4.5M | Buy |
220,106
+134,269
| +156% | +$2.75M | 0.09% | 369 |
|
|
2021
Q3 | $2.19M | Buy |
+85,837
| New | +$2.19M | 0.05% | 467 |
|
|
2017
Q3 | – | Sell |
-1,240,391
| Closed | -$4.42M | – | 754 |
|
|
2017
Q2 | $4.42M | Buy |
1,240,391
+426,269
| +52% | +$1.52M | 0.08% | 440 |
|
|
2017
Q1 | $4.21M | Buy |
814,122
+961
| +0.1% | +$4.97K | 0.07% | 462 |
|
|
2016
Q4 | $3.09M | Buy |
813,161
+685,080
| +535% | +$2.6M | 0.05% | 525 |
|
|
2016
Q3 | $1.15M | Buy |
+128,081
| New | +$1.15M | 0.02% | 644 |
|